ANRim Biotechnology
Nanotechnology for Healthcare!

Bring Advanced Cell Engineering and Transcriptomics to Clinical Practice with affordable cost to Patients

learn more

About

AnRim Biotechnology Co., Ltd. (ANRim) was founded in 2023. Its core team, hailing from City University of Hong Kong, has over a decade of experience in nanotechnology and biotechnology R&D. The company focuses on integrating nanotechnology with precision medicine, developing gene delivery and detection technologies based on nanoneedle array biochips and has been granted over 20 patents.

We are committed to advancing affordable, next-generation cell therapy and gene editing solutions and becoming an innovative pioneer in this field.

learn more

Solution

At ANRim Biopharm, we are committed to applying advanced cell engineering and transcriptomics technologies to clinical practice at a cost that patients can afford.

Technology

Transfection of Primary Neuron Cells

Conventional methods, such as liposome transfection, are largely ineffective in primary neurons, with efficiencies below 3%. At ANRim, our scientists have optimized intracellular delivery and cell engineering technologies specifically for neuronal cells.

Production of induced pluripotent stem cells (iPSC)

Induced pluripotent stem cells (iPSCs) are a type of stem cell generated by artificially reprogramming adult somatic cells, such as skin or blood cells, back to a pluripotent state.

Engineering lyphocytes for immune therapy

Immunotherapy represents a frontier in the treatment of cancer and other diseases. At ANRim, our scientists engineer lymphocytes to enhance the production of clinically valuable cells, ultimately benefiting patients.

Cell manufacturing quality control

Quality control in the manufacturing of therapeutic cells is essential to ensure that cell-based therapies can be applied safely and effectively.

Affordable spatial transcriptomics for diagnostics

A major bottleneck for the clinical translation of spatial transcriptomics in biological research is its high cost.

In-body spatial transcriptomics

ANRim has developed a novel integrated biochip endoscopic system that enables transcriptome analysis directly on internal human organs through an “touch-and-go” RNA extraction process.

News

Learn More News

城大基因，峰会绽放！安瑞生物核心团队携技术成果亮相国际医疗创新盛会

Exhibition Highlights: AnRui Bio Shines at the 3rd TICSSO Conference, Focusing on Single-Cell and Spatial Omics

The 3rd TICSSO International Conference on Single-Cell and Spatial Omics was held at the Caohejing Conference Center in Shanghai, with the theme “Life and Health in the Single-Cell Spatial Landscape.”

Exhibition Highlights: Empowering Innovation — AnRui Bio at the 8th Asia Cell & Gene Therapy Summit

The 8th Asian Cell and Gene Therapy Innovation Summit, CGT Asia 2025, concluded on April 3 in Pudong, Shanghai.

Contact ANRim

Receive the latest news and insights in your inbox.